Skip to main content

CardiaTec Biosciences

Cambridge, United Kingdom

CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.

$6.5M raised
Sep 2024
Seed

Top Investors

Montage VenturesO2h VenturesUniversity of Cambridge EnterpriseCrista Galli VenturesContinuum Health Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about CardiaTec Biosciences

How much funding has CardiaTec Biosciences raised?
CardiaTec Biosciences has raised $6.5M in total funding. The most recent round was Seed. The last funding was announced in September 2024.
Who are CardiaTec Biosciences's investors?
CardiaTec Biosciences's investors include Montage Ventures, O2h Ventures, University of Cambridge Enterprise, Crista Galli Ventures, Continuum Health Ventures.
Where is CardiaTec Biosciences headquartered?
CardiaTec Biosciences is headquartered in Cambridge, United Kingdom.
What does CardiaTec Biosciences do?
CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.
What stage is CardiaTec Biosciences at?
CardiaTec Biosciences is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"CardiaTec Biosciences — Funding & Investors." VCBacked, September 10, 2024, https://www.vcbacked.co/company/cardiatec-biosciences. Accessed June 4, 2026.
APA
VCBacked. (2024). CardiaTec Biosciences — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/cardiatec-biosciences
Wikipedia (cite web)
{{cite web |title=CardiaTec Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/cardiatec-biosciences |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .